Savolitinib Combo Earns Priority Review in China for EGFR+ NSCLC
Findings from the phase 3 SACHI trial support the National Medical Products Administration’s priority review designation for savolitinib/osimertinib.
Related Articles
FDA Grants Priority Review to Sunvozertinib for EGFR exon20 NSCLC
The WU-KONG1 trial found that sunvozertinib yielded a best ORR of 53.3% and a cORR of 44.9% in patients with NSCLC harboring EGFR exon20ins mutations.
How Does Alcohol Consumption Impact Cancer Risk?
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers.
Optimal Disitamab Vedotin Dose for Patients With Chemotherapy-Refractory Advanced Urothelial Carcinoma
According to results from the phase 1b/2 RC48-C014 study, the addition of 2 mg/kg of disitamab vedotin to toripalimab is preferable to 1.5 mg/kg among…
Cost and activity analysis for a citywide patient navigation intervention to engage underserved patients in breast cancer treatment: Findings from the Translating Research Into Practice study
This study presents findings from a cost and activity analysis of a citywide hospital-based patient navigation program to engage women in timely breast cancer treatment…
December 2024 OSUCCC – James Grants, Awards and Honors
The OSUCCC – James announces the following awards, honors, grants and more that were recently given to the organization, teams or individuals.
Regular physical activity prior to cancer diagnosis reduces progression, mortality risk
Regular physical activity prior to a cancer diagnosis lowered a patient’s risk for disease progression and death, according to study findings.Even small amounts of physical…
Fixed-Duration Zanubrutinib/Venetoclax Shows Efficacy in R/R Chronic Lymphocytic Leukemia
Fixed-duration zanubrutinib/venetoclax elicited responses in patients with relapsed/refractory chronic lymphocytic leukemia.
FDA Fast Tracks Abenacianine for Lung Cancer Surgery
Abenacianine, a tumor-targeted fluorescent imaging agent, received fast track designation from the FDA after demonstrating its safety and efficacy in visualizing lung tumors in a…
Designing observational studies to estimate treatment effects in geriatric oncology: A closer look at confounding and its mitigation
Adults aged 70 or over account for more than a third of all new cancer diagnoses globally [1]. Despite continuous efforts in the last decades,…
FDA Issues Draft Guidance for Accelerated Approval Confirmatory Clinical Trials
The FDA released a draft guidance document detailing their interpretation of when a confirmatory clinical trial for an accelerated approval is underway.